Antibody Manufacturing Explained: What Every Researcher Should Know

Are you in the field of medical research, diagnostics, and treatment? Okay! You are aware of antibodies and its importance in labs or therapies. Plus, these antibodies should be produced in a controlled, consistent, and reproducible manner. Right? Now this antibody manufacturing is no simple job because it involves a number of careful and detailed steps.

Whether you are new to this field or starting a research project that involves antibodies, then you must understand how they are produced. Why? Quite simple - this helps you plan better, reduce costs, and improve results.

This guide is all about explaining the antibody synthesis process in simple language. And, it focuses especially on monoclonal antibody manufacturing (since this is one of the most common and useful methods in modern science).

Antibody Manufacturing in a Nutshell:

Antibody production is the in-lab procedure of making antibodies outside the body. Here, researchers can produce polyclonal or monoclonal antibodies, based on the unique project requirement.

Now, Polyclonal antibodies are a collection of different antibodies that bind to various regions of the same antigen.

And, the Monoclonal antibodies (mAbs), on the other hand, are identical antibodies that bind to a single site on an antigen. They are widely used in research, diagnostics, and treatment (particularly cancer, autoimmune diseases, and infectious diseases).

Stages of Antibody Synthesis:

Antigen Preparation:

It all starts with the antigen, the material to which the antibody will bind and recognise. It can be a protein, virus, or toxin. The purity and quality of the antigen are very crucial since it determines the quality of the end product, the antibody.

Immunization:

Here, selected animals (most often mice, rabbits, or goats) are injected with the antigen. Why? To trigger their immune system. What happens after that is gradually, their body starts producing antibodies against the antigen.Mice are commonly used for best monoclonal antibody production. Cell Fusion and Hybridoma Creation (For Monoclonal Antibodies)

After the sufficient antibodies (generated from the mouse) , researchers harvest B-cells (a kind of white blood cell) from its spleen. Next, they are then joined with myeloma (cancer) cells. The purpose? To form hybridoma cells. These unique cells have the potential to survive indefinitely and secrete great quantities of one kind of antibody.

Screening and Selection:

Next, these hybridoma cells are tested to identify which cells are producing the target antibody. How is it done? Well, for this, the tests such as ELISA (enzyme-linked immunosorbent assay) is conducted.

It helps choose the highest-performing hybridomas which are selected for further cultivation.

Antibody Production:

Okay, now after the appropriate hybridoma cells have been identified, they are further cultured in bioreactors or culture flasks. These systems supply the nutrients and conditions that are necessary to produce antibodies on a scale.

Purification:

Next comes the purification. The antibodies produced are combined with other proteins and waste materials. The goal is always to achieve pure antibodies, and that’s why they need to undergo purification methods like:

• Protein A/G chromatography
• Ion exchange chromatography
• Ultrafiltration

This process makes the antibodies safe, pure, and functional.

Quality Control and Characterization

Antibodies are tested rigorously before being shipped or utilized to ensure:

• Purity
• Concentration
• Binding activity
• Stability

All of that is required to adhere to regulatory requirements, particularly for clinical applications.

Challenges Researchers May Face:

Despite the simplicity of the process, researchers need to be cognizant of potential issues:

• Batch-to-batch inconsistency of animal response
• Low yields of antibodies from hybridomas
• Labor-intensive screening
• Extensive cost of bioreactors and purification equipment
• Regulatory barriers to clinical-grade antibodies

Collaboration with a reliable antibody producer or contract research organisation will mitigate many of these problems.

Final words:

No matter whether you are developing Western Blot, ELISA, immunohistochemistry, or a highly specialized assay, selecting the right partner is essential.

Bio Basic provides a full-service offering from antigen design to antibody purification, with no extra costs, free additional boosts, and peptide design. Our easy pricing scheme and weekly progress reports keep you up to date and never overpay. Most importantly, Bio Basic stands behind its functionality guarantee, such as ELISA titer guarantees of >1:100,000 for monoclonal and >1:50,000 for polyclonal antibodies.

Visit our website for more details! Or, get an estimate now!

Significance of Custom Antibody Production to Research Applications

In biology and medicine research and development has a long history with antibody reproducibility. In fact, biology-based studies show the major contribution of using antibodies in the basic understanding of the subject. However, these antibodies are also a significant factor in poor reproducibility according to different research. In today's blog, we will take an insight into those studies reflecting the importance of antibody manufacturing in biology research and medicinal development. Keep reading.

Why Is Antibody Reproducibility Important in Research and Development?

Of multiple biology-based studies and research, one study by the Human Protein Atlas shows how antibody generation significantly impacts research applications and where its importance lies. This Swedish consortium manufactures around 9,000 antibodies internally, directing them against human genome proteins to evaluate their efficacy through bioinformatics and experimental data. In the outcome, it’s found that less than 50% of the protein distribution in the preserved tissue slices is active.

In another study, researchers assessed 246 antibodies mostly used in epigenetics fields, where the outcomes reveal that 25% of those reagents failed the test due to displaying a high specificity for wrong molecular targets. That’s why antibody quality issues have become a challenge for researchers.

However, the experts keep taking numerous initiatives to facilitate data availability on antibody quality to improve validation standards as reagents. And, at a point of investigation, they have found out the reasons behind the poor performance of antibodies, whether buying from any commercial sources or generated in-house in research applications. In most cases, this performance failure can occur due to shortcuts, technical oversights or incomplete characterization.

Moreover, custom antibody production is complicated, and each phase can have a significant impact depending on various factors during the creation process. Yet, you need to take careful considerations during every step of the research applications as reagents. It will help you identify the difference between poor-quality antibodies and exceptional ones. For example:

• Exception antibodies come with high specificity and avidity, while poor-quality antibodies contain no or low avidity and specificity.
• Poor-quality antibodies mostly contaminate mycoplasma and viruses with low expression levels. However, with exceptional antibodies, researchers can take advantage of its intended biological function and correct Fc domains. Also, the latter offers proper stability and glycosylation with other desired traits.

When using poor-quality antibodies as a reagent in research applications, it requires characteristic re-optimization from scratch. However, the process can be highly expensive and cause delays in new antibody manufacturing, where the timeline depends on the type of antibody used for your research application, like monoclonal antibody production or polyclonal antibody production.

Being a researcher, the best thing you can do here is to make an upfront investment for the optimization process, ensuring antibody generation meets your needs for the long term. It may increase the initial investment amount and pre-production timeline. But you can save or reduce costs on the scientific and financial consequences of using poor-quality antibodies in the research. So, rely on high-quality antibodies, whether generated in-house or commercially, outsourcing to obtain reproducible and consistent data.

In Conclusion

From the selection to antigen preparation, every step requires careful planning when aiming to develop exceptional antibodies and up-front investment, which increases the chances of high-quality antibody generation. However, if you are looking to save your time and effort, rely on us, Bio Basic, for commercially sourcing antibodies, whether it be chimeric monoclonal antibodies or polyclonal ones.

Just decide which one is the best fit for your application and ask for the results you desire. Our antibody synthesis packages provide the utmost freedom to researchers for antibody synthesis, from cDNA to protein to peptide, and ensure successful basic research applications in the projects of your choice. We have a qualified team of scientists to help you find the best package considering your research goals while informing you about the outcomes throughout the process.

Request a quote now or download our order form and email that to our antibody department at antibody@biobasic.com today!